Ahp40825
Mesalamine Tablet, Delayed Release
Product Images NDC 60687-408
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 60687-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Blister
Carton
This is a medication called Mesalamine that is available in tablet form. It is a delayed-release tablet that should not be cut, broken or chewed. The recommended dosage for treating moderately active ulcerative colitis is usually two 800mg tablets to be taken three times a day with or without food, for a total daily dose of 4.8g, for six weeks. It is important to keep this and all other drugs out of reach of children. The drug product is distributed by American Health Packaging, Columbus.*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
